WNK2 and Erdheim-Chester disease: Erdheim-Chester disease (ECD) is a rare non-Langerhans histiocytosis increasingly recognized as a clonal myeloid disorder driven by mutations in the mitogen-activated protein kinase (MAPK) signaling pathway—most notably the BRAF V600E mutation (11, 12).